Top Markets
#1 Akedo Akedo +59.32%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.39%
#4 Velvet Velvet +43.06%
#5 Black Phoenix Black Phoenix +34.58%
#6 τemplar τemplar +22.94%
#7 Cap Cap +19.28%
#8 Ribbita by Virtuals Ribbita by Virtuals +17.53%
#9 Cross Cross +17.30%
#10 Bitway Bitway +15.59%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Classement en actions #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Prix de l'action
$0.08765138
Dernière synchronisation: 2025-12-23
Capitalisation boursière
$1.11M
Changement (1 jour)
0.45%
Changement (1 an)
-28.78%
Pays
CA
Échange Psyence Group Inc. (PSYG)

Catégorie

Healthcare
Historique du prix de l'action pour Psyence Group Inc. (PSYG)
Prix de clôture le plus élevé : $0.09 le 2025-12-01

Prix de clôture le plus bas : $0.17 le 2021-01-01
Historique du prix de l'action de Psyence Group Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 10.84%
2025 -20.78%
2024 -39.49%
2023 111.53%
2022 -39.61%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.18K 72.71%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $260.38 49.03%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $249.16 21.73%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $470.54 44.82%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $135.64 63.90%
US